← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 1, 2008Last known activity
Nov 26, 2023
Timeline
2000s
- Apr 1, 2007
Constant Pharmaceuticals— Founded
Drugs by trial phase (2 distinct, 12 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Congenital Abnormalities
- Graft vs Host Disease
- HIV Infections
- Hodgkin Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, Non-Hodgkin
- Lymphopenia
- Metabolic Diseases
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms
- Neoplasms, Plasma Cell
- Neutropenia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Syndrome
- Thrombocytopenia
Recent trials (14)
- NCT06135103Lead sponsorPhase 2Nov 26, 2023
- NCT06013839Lead sponsorPhase 2Aug 31, 2023
- NCT06013839Study chairPhase 2Aug 31, 2023
- NCT04605887CollaboratorPhase 2Nov 30, 2020
- NCT04605887CollaboratorPhase 2Nov 30, 2020
- NCT01882387Lead sponsorPhase 2Dec 1, 2013
- NCT01882374Lead sponsorPhase 2Dec 1, 2013
- NCT01554254Lead sponsorPhase 2Mar 1, 2012
- NCT01362036Lead sponsorPhase 1Apr 1, 2011
- NCT01300611Lead sponsorPhase 1Jan 1, 2011
- NCT01121120Lead sponsorPhase 2Jun 1, 2010
- NCT01543971Lead sponsorPhase 1Dec 1, 2009
- NCT00771810Lead sponsorPhase 2Oct 1, 2008
- NCT00757250CollaboratorPhase 1Sep 1, 2008
Details
- Founded
- Brookline, MA, US Apr 1, 2007
- Last known activity
- Nov 26, 2023
Notes
formerly Tarix Orphan